SEC Form 4 · accession 0001445064-15-000132
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Coleman N Lannum III
Officer — SVP, Investor Strategy & IRO
Period of report
Nov 10, 2015
Accepted (ET)
Nov 10, 2015 · 12:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Nov 10, 2015 | P | 300 | $57.53 | A | 8,886 | D | |
| Ordinary Shares | holding | — | — | — | 500 | I | By wife | |
| Ordinary Shares | holding | — | — | — | 75 | I | By son (M) | |
| Ordinary Shares | holding | — | — | — | 45 | I | By son (R) | |
| Ordinary Shares | holding | — | — | — | 45 | I | By son (S) | |
| Ordinary Shares | holding | — | — | — | 20 | I | By mother |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 4, 2015.
- F2Includes 63 shares acquired on October 8, 2015 and 135 shares acquired on November 9, 2015 under the Mallinckrodt employee stock purchase plan.